T3	Effect 0 22	Serious adverse events
T5	Treatment 81 95	spironolactone
T4	Subject 38 73	patients with chronic heart failure
T7	Sub-Disorder 52 73	chronic heart failure
T9	Drug 81 95	spironolactone
